Colorectal Cancer Pipeline Report: Guide Features Descriptive Drug Profiles & Other Developmental Activities
Jul 5, 2018
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Colorectal Cancer - Pipeline Review, H1 2018, provides an overview of the Colorectal Cancer (Oncology) pipeline landscape.
Pune, India - July 5, 2018 /MarketersMedia/ —
Colorectal cancer is a cancer that starts in the colon or the rectum. Colorectal cancers begin as a growth called a polyp on the inner lining of the colon or rectum. Symptoms include abdominal pain and tenderness in the lower abdomen, blood in the stool, diarrhea, constipation, change in bowel habits, narrow stools and weight loss with no known reason. Risk factors include smoking, heavy alcohol use, inflammatory bowel disease (IBD) and family history. Treatment includes surgery, radiation therapy and chemotherapy.
Report Source: https://www.themarketreports.com/report/colorectal-cancer-pipeline-review-h1-2018
Scope
• The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
• The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
• The pipeline guide reviews key companies involved in Colorectal Cancer (Oncology) therapeutics and enlists all their major and minor projects.
• The pipeline guide evaluates Colorectal Cancer (Oncology) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
• The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
• The pipeline guide reviews latest news related to pipeline therapeutics for Colorectal Cancer (Oncology)
Purchase this report at: https://www.themarketreports.com/report/buy-now/1206000
Reasons To Buy
• Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
• Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
• Find and recognize significant and varied types of therapeutics under development for Colorectal Cancer (Oncology).
• Classify potential new clients or partners in the target demographic.
• Develop tactical initiatives by understanding the focus areas of leading companies.
• Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
• Formulate corrective measures for pipeline projects by understanding Colorectal Cancer (Oncology) pipeline depth and focus of Indication therapeutics.
• Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
• Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
Got a question; ask us at: https://www.themarketreports.com/report/ask-your-query/1206000
Contact Info:
Name: Shirish Gupta
Email: [email protected]
Organization: The Market Reports
Address: SF-29, Sacred World, Wanawadi
Phone: 16314071315
For more information, please visit https://www.themarketreports.com/report/colorectal-cancer-pipeline-review-h1-2018
Source: MarketersMedia
Release ID: 372759
More News
A Fight Over Felon Voting Prompts a Free Speech Debate
A Minnesota group worried that its opposition could expose it to prosecution under the state’s deceptive-practices law. Its lawsuit could have wide implications for limiting speech around elections.
Noah Adams, Longtime Host of ‘All Things Considered,’ Has Died at 84
A postman’s son from Kentucky, he worked hard to lose his accent but never forgot his Appalachian roots. “The best stories come from west of the Potomac,” he said.
How to Straddle the MAGA Divide
Beth Wilkinson is a Washington lawyer who has thrived representing the Trump administration’s enemies and allies alike. Does she represent a vanishing type?
C.E.O.s Say the A.I. Rollout Is Going Well. Employees Feel Differently.
Surveys show workers and executives have different views on A.I.
Audi to Build Factory in Georgia, Trump Says
The Volkswagen division, which imports all its cars from Europe or Mexico, has been hit hard by U.S. tariffs.
Former ‘60 Minutes’ Boss to Join Video Journalism Start-Up
Bill Owens, who left the show after clashing with CBS executives, is joining Newpress, which publishes work from creators on YouTube.
Public Colleges Are Passing the $50,000-a-Year Mark. For Locals.
At the University of California campuses in Berkeley, Irvine and Santa Barbara, students get an unwitting education in navigating the housing market.
100 million import orders? Yiwu did it in a flash!
China's Yiwu has just hit 100 million import orders for 2026, a full 40 days earlier than the previous year. The world's wholesale market is now the world's shopping cart!
Global funding for nature still falling short: Paulson Institute
Global funding for nature still falling short: Paulson Institute
Budget to include £1bn for social and affordable housing
The move will take funding for the 10-year programme to more than £40bn.
Schroders: China's capital market opening deepens two-way connectivity
China's capital market opening-up is a very positive long-term development that deepens two-way connectivity between China and international capital markets, said Yu Xueyu, CEO of Schroders Hong Kong, in an interview with CGTN.
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.